This early-stage study tested a single injection of a new drug called SYN321 in 35 people with painful knee osteoarthritis. The main goals were to check if the injection is safe and to get an early look at whether it might help ease pain. Participants received one of three doses …
Phase: PHASE1, PHASE2 • Sponsor: Synartro AB • Aim: Symptom relief
Last updated May 17, 2026 13:56 UTC